A data-driven computational model for obesity-driven diabetes onset and remission through weight loss

被引:2
作者
Yildirim, Vehpi [1 ,2 ]
Sheraton, Vivek M. [2 ,3 ,4 ]
Brands, Ruud [5 ,6 ]
Crielaard, Loes [1 ,2 ]
Quax, Rick [2 ,3 ]
van Riel, Natal A. W. [7 ,8 ]
Stronks, Karien [1 ,2 ]
Nicolaou, Mary [1 ,2 ]
Sloot, Peter M. A. [2 ,3 ]
机构
[1] Univ Amsterdam, Amsterdam Univ, Dept Publ & Occupat Hlth, Med Ctr, NL-1081 BT Amsterdam, Netherlands
[2] Univ Amsterdam, Inst Adv Study, NL-1012 GC Amsterdam, Netherlands
[3] Univ Amsterdam, Computat Sci Lab, NL-1098 XH Amsterdam, Netherlands
[4] Univ Amsterdam, Ctr Expt & Mol Med, Acad Med Ctr, Med Ctr, NL-1100 DD Amsterdam, Netherlands
[5] AMRIF BV, Agro Business Pk, NL-6708 PW Wageningen, Netherlands
[6] Univ Utrecht, Inst Risk Assessment Sci, NL-3584 CL Utrecht, Netherlands
[7] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands
[8] Univ Amsterdam, Dept Expt & Vasc Med, Med Ctr, NL-1100 DD Amsterdam, Netherlands
关键词
BETA-CELL MASS; FREE FATTY-ACID; INDUCED INSULIN-RESISTANCE; Y GASTRIC BYPASS; ECTOPIC FAT; GLUCOSE-TOLERANCE; BARIATRIC SURGERY; EARLY IMPROVEMENT; INFLAMMATION; RISK;
D O I
10.1016/j.isci.2023.108324
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity is a major risk factor for the development of type 2 diabetes (T2D), where a sustained weight loss may result in T2D remission in individuals with obesity. To design effective and feasible intervention strategies to prevent or reverse T2D, it is imperative to study the progression of T2D and remission together. Unfortunately, this is not possible through experimental and observational studies. To address this issue, we introduce a data-driven computational model and use human data to investigate the progression of T2D with obesity and remission through weight loss on the same timeline. We identify thresholds for the emergence of T2D and necessary conditions for remission. We explain why remission is only possible within a window of opportunity and the way that window depends on the progression history of T2D, individual's metabolic state, and calorie restrictions. These findings can help to optimize therapeutic intervention strategies for T2D prevention or treatment.
引用
收藏
页数:25
相关论文
共 106 条
  • [61] Relationship Between Body Fat Mass and Free Fatty Acid Kinetics in Men and Women
    Mittendorfer, Bettina
    Magkos, Faidon
    Fabbrini, Elisa
    Mohammed, B. Selma
    Klein, Samuel
    [J]. OBESITY, 2009, 17 (10) : 1872 - 1877
  • [62] Association between inflammatory biomarkers and adiposity in obese patients with heart failure and metabolic syndrome
    Motie, Marjan
    Evangelista, Lorraine S.
    Horwich, Tamara
    Lombardo, Dawn
    Zaldivar, Frank
    Hamilton, Michele
    Fonarow, Gregg C.
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 8 (01) : 181 - 186
  • [63] β-Cell Death in Diabetes: Past Discoveries, Present Understanding, and Potential Future Advances
    Mukherjee, Noyonika
    Lin, Li
    Contreras, Christopher J.
    Templin, Andrew T.
    [J]. METABOLITES, 2021, 11 (11)
  • [64] Mechanisms of weight loss and improved metabolism following bariatric surgery
    Mulla, Christopher M.
    Middelbeek, Roeland J. W.
    Patti, Mary-Elizabeth
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1411 (01) : 53 - 64
  • [65] Does Metabolically Healthy Obesity Exist?
    Munoz-Garach, Araceli
    Cornejo-Pareja, Isabel
    Tinahones, Francisco J.
    [J]. NUTRIENTS, 2016, 8 (06)
  • [66] Cardiovascular and Metabolic Heterogeneity of Obesity Clinical Challenges and Implications for Management
    Neeland, Ian J.
    Poirier, Paul
    Despres, Jean-Pierre
    [J]. CIRCULATION, 2018, 137 (13) : 1391 - +
  • [67] Insulin-sensitive and insulin-resistant obese and non-obese phenotypes: role in prediction of incident pre-diabetes in a longitudinal biracial cohort
    Owei, Ibiye
    Umekwe, Nkiru
    Provo, Casey
    Wan, Jim
    Dagogo-Jack, Samuel
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2017, 5 (01)
  • [68] Effects of IL-1 beta-Blocking Therapies in Type 2 Diabetes Mellitus: A Quantitative Systems Pharmacology Modeling Approach to Explore Underlying Mechanisms
    Palmer, R.
    Nyman, E.
    Penney, M.
    Marley, A.
    Cedersund, G.
    Agoram, B.
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2014, 3 (06):
  • [69] Evaluation of quantitative models of the effect of insulin on lipolysis and glucose disposal
    Periwal, Vipul
    Chow, Carson C.
    Bergman, Richard N.
    Ricks, Madia
    Vega, Gloria L.
    Sumner, Anne E.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2008, 295 (04) : R1089 - R1096
  • [70] Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
    Perry, Rachel J.
    Peng, Liang
    Cline, Gary W.
    Wang, Yongliang
    Rabin-Court, Aviva
    Song, Joongyu D.
    Zhang, Dongyan
    Zhang, Xian-Man
    Nozaki, Yuichi
    Dufour, Sylvie
    Petersen, Kitt Falk
    Shulman, Gerald I.
    [J]. CELL METABOLISM, 2018, 27 (01) : 210 - +